Fundraising Fox

MaveriX Oncology

Palo Alto, US · Founded 2015 · Delaware corporation

Maverix Oncology develops conditionally activated small molecule therapeutics for cancer treatment, led by a team of oncologists and cancer scientists with experience in drug discovery and development.

Founders & leadership

SA
Steven A. EverettNamed on SEC filing

Board

RP
Rick PanicucciBoard director

Reported raises · per SEC filings

Form D private placements

$2.8M disclosed across 2 rounds · 2016–2019

$1.8MraisedOct 2019 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven A. EverettExecutive Officer, Director
  • Riccardo PanicucciDirector
  • Kim NearingDirector
  • Norbert PrenzelDirector
Offering amount
$20M
Amount sold
$1.8M
Finders' fees
$180K
Placement agents
Katalyst Securities LLC
First sale
Sep 2019
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1000KraisedJun 2016 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven A. EverettExecutive Officer, Director
  • Rick PanicucciDirector
Offering amount
$1000K
Amount sold
$1000K
First sale
May 2016
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Companies competing with MaveriX Oncology for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does MaveriX Oncology do?
Maverix Oncology develops conditionally activated small molecule therapeutics for cancer treatment, led by a team of oncologists and cancer scientists with experience in drug discovery and development.
How much funding has MaveriX Oncology raised?
MaveriX Oncology has disclosed $2.8M raised across 2 rounds.
Where is MaveriX Oncology headquartered?
MaveriX Oncology is headquartered in Palo Alto, US.